MARKET WIREReuters • 3h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
Why ATEC Stock slipped -0.70% Today — RQD Quant Desk Flash
$11.37 -0.70% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $11.33
Alphatec Holdings Inc. (ATEC) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $1.76B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $11.33 (-0.32%)🧬 Dilution Drag (+1.92% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0.4% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.8% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-9% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ATEC)Realized 20D OHLCV Swing Band: ±12.2%
Deterministic 5-Pillar Attribution (38/100 Composite)
🔍 WHY ATEC SCORES 38/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+12/20 pts (32% of score)
SEC XBRL FY 2025 (10-K): 0.4% FCF Margin ($2.8M FCF) & 69.6% Gross Margin
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+9/20 pts (24% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 6/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)
Dilution Drag (+1.92% YoY Shares) & executive Form 4 sales trim 15 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$10.67-2% Next Q
30
Q2 (-2Q)Grade E$10.46+6.2% Next Q
33
Q3 (-1Q)Grade E$11.11+2.3% Next Q
35
CurrentGrade D-$11.37-7.8% Hist 90D α
38
Trajectory: E (30) → D- (38)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a ATEC Turnaround Squeeze
While ATEC currently carries a cautious 38/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($10.14) and Max Pain ($11.94) forces dealer call-delta covering toward $24.45.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $ATEC• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ATEC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ATEC Stock slipped -0.70% Today — RQD Quant Desk Flash
Alphatec Holdings Inc. (ATEC) slipped -0.70% to $11.37, trading at 28% of its 52-week range ($6.81 – $23.29). Stretched risk/reward at current multiples (-18% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 28% of its 52-week range ($6.81 – $23.29) with RSI-14 at 27.2 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.2% around $11.37 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 69.6% gross margin and $2.8M annual free cash flow.
Live ATEC Headlines & Catalysts
MARKET WIRECNBC • 5h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 5h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 7h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 8h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 9h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 9h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 10h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ATEC)
- ✓Walkthrough of ATEC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ATEC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +16.50%▲ ASCENDING CHANNEL
2026-10-30O $6.86H $11.37L $6.81C $11.37VOL 27.29M
RES: $13.53SUP: $9.21SMA50: $10.14SMA200: $10.56
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ATEC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ATEC today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ATEC. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ATEC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ATEC)
Health Care Rank #699 of 1016
⚔️ KMTS vs ATEC Full Matrix →
1. Head-to-Head Health Care Peer Comparison (ATEC vs. KMTS, XRAY, LMAT, NVCR)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Alphatec Holdings Inc. (ATEC) ranks #699 by composite RQD confidence (38/100, grade D-) and #280 by equity capitalization ($1.76B). Within this direct 5-issuer industry benchmark cohort, LMAT leads on earnings valuation at 33.8x trailing P/E, while LMAT leads on capital efficiency and profitability with 14.7% ROIC and 71.5% gross margin. LMAT currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with ATEC at 38/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ATEC
ACTIVE
Alphatec Holdings Inc. | D- | 38/100 | — | 69.6% | -18.4% | -0.70% | $1.76B | Benchmark Subject |
| KMTS Kestra Medical Technologies Ltd. | D- | 43/100 | — | 51.4% | -35.0% | +2.48% | $1.82B | /kmts-vs-atec → |
| XRAY DENTSPLY SIRONA Inc. | D | 46/100 | — | 50.0% | -11.0% | +1.80% | $1.92B | /xray-vs-atec → |
| LMAT LeMaitre Vascular Inc. | B | 74/100 | 33.8x | 71.5% | 14.7% | +2.90% | $1.95B | /lmat-vs-atec → |
| NVCR NovoCure Limited | E | 24/100 | — | 74.5% | -27.5% | -7.48% | $1.53B | /nvcr-vs-atec → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001350653In its most recent audited fiscal period (FY2025, filed 2025-12-31), Alphatec Holdings Inc. (ATEC) reported GAAP revenue of $764.2M (+25.0% vs. FY2024 revenue of $611.6M ) , GAAP net income of -$143.4M, operating cash flow of $45.2M, and free cash flow of $2.8M (+102.2% YoY). On the balance sheet, ATEC closed FY2025 with $791.2M in total assets against $501.4M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $764.2M | -$143.4M | $45.2M | $2.8M | $791.2M | $501.4M |
| FY2024 (FY) | 2024-12-31 | $611.6M | -$162.1M | -$44.7M | -$127.9M | $775.7M | $574.5M |
| FY2023 (FY) | 2023-12-31 | $0 | -$186.6M | -$78.5M | -$78.5M | — | — |
3. ATEC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ATEC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Alphatec Holdings Inc. (NASDAQ: ATEC) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $11.37 (-0.70% 1D, market cap $1.76B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, ATEC ranks #699 in composite RQD confidence.
How does ATEC compare to KMTS and XRAY in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), ATEC carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 69.6%, and ROIC of -18.4%. By comparison, KMTS (Kestra Medical Technologies Ltd.) holds a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $1.82B) and XRAY (DENTSPLY SIRONA Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC -11.0%, cap $1.92B). Among the 5-stock peer group, LMAT leads on earnings multiple (33.8x) while LMAT leads on capital efficiency (14.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ATEC?
Per ATEC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001350653), Alphatec Holdings Inc. generated $764.2M in revenue (+25.0% YoY), -$143.4M in net income, and $2.8M in free cash flow against $791.2M in total assets and $501.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ATEC trading relative to its 50-day, 200-day, and 52-week technical levels?
ATEC last traded at $11.37 (-0.70% on volume of 7,217,866 shares), positioning the stock +12.13% above its 50-day simple moving average ($10.14) and +7.67% above its 200-day simple moving average ($10.56). Across its 52-week range of $6.81 to $23.29, ATEC sits at the 27.7% percentile with a 14-day RSI of 27.2 (OVERSOLD (<32)) and an implied next-earnings move of ±12.2% ($9.98 to $12.76).
ATEC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ATEC stock moving today?
Why ATEC Stock slipped -0.70% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-18% return on capital) under elevated 10-year interest-rate pressure.